NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Bayer back to previous page show list

Bayer

»
address: Pharmaceutical Division
Bayer plc
Bayer House
Strawberry Hill
Newbury
Berkshire
RG14 1JA
United Kingdom
contact: Tel: +44 (0)1635 563000
For medical information, contact:
e-mail: medical.science@ bayer.co.uk
key person: Manfred Schneider
Chairman of the Supervisory Board, Leverkusen
* December 21, 1938
DaimlerChrysler AG
Linde AG (Chairman)
Metro AG
RWE AG
TUI AG


Dr. Paul Achleitner
Member of

trunover in millions USD: 38726
R & D turnover in millions USD: 3072
NET profit: 3694
year of financial results: 2006
employees: 106000

active in China: YES
partner in China: Bayer (China) Limited (Shanghai, Beijing, Guangzhou)
- Bayer (Sichuan) Animal Health Co., Ltd. (Chengdu)
- Bayer Coatings Systems Shanghai Co., Ltd. (Shanghai)
- Bayer Guangyi Panel Co., Ltd. (Beijing)
- Bayer Healthcare Co., L

SFDA approved: NO

Approvals:
GLP: NO
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: NO
Quality Control: NO
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: NO

Non clinical & preclinical:
Animal Testing: GLP: NO
New materials Safety Assessment: NO
Pharmaceuticals: NO
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 
Central service functions are combined into three service companies:
 
Bayer Business Services GmbH is the Bayer Group's international competence center for IT-based services. 
Bayer Technology Services GmbH, the technological backbone of the Bayer Group, is engaged in process development and in process and plant engineering, construction and optimization. 
Bayer Industry Services GmbH & Co. OHG is the operator of Germany's largest chemical park network, with sites at Leverkusen, Dormagen and Krefeld-Uerdingen.
  
Dual governance system with the following governance bodies:
 
Board of Management: four members, Chairman: Werner Wenning 
Supervisory Board: 20 members, Chairman: Dr. Manfred Schneider
 
Business operations are the responsibility of the subgroups:
 
Bayer HealthCare AG researches, develops, manufactures and markets innovative products for disease prevention, diagnosis and treatment. 
Bayer CropScience AG is a global leader in crop protection and non-agricultural pest control. 
Bayer MaterialScience AG is a renowned supplier of high-performance materials and innovative system solutions used in a wide range of products for everyday life.
 
Greater China is Bayer's second largest single market in Asia, accounting for approximately one quarter of regional sales. Our interests in this exciting region have grown steadily over the years, from step-by-step investment in the early 1990s to large-scale, world-class facilities today. Bayer's investment in our integrated production site in the Shanghai Chemical Industry Park makes it evident that Bayer regards Greater China as one of its most important markets worldwide.
 
Bayer's Greater China Group operates in the market encompassing Hong Kong, Taiwan, and the People's Republic of China. The Bayer Group in Greater China is led by management holding companies, with the subgroups and production joint ventures operating independently under their strategic direction. President of Bayer Greater China Group, Dr. Juergen Dahmer leads the Group in Greater China.
 
The Greater China Group employs ca. 3,700 people across a wide range of functions.Bayer currently operates 19 companies in Greater China. Eight of them now have production facilities on stream in all business segments in which the company is active. Local production accounts for an increasing proportion of sales.
 
PR China:
 
- Bayer (China) Limited (Shanghai, Beijing, Guangzhou)
- Bayer (Sichuan) Animal Health Co., Ltd. (Chengdu)
- Bayer Coatings Systems Shanghai Co., Ltd. (Shanghai)
- Bayer Guangyi Panel Co., Ltd. (Beijing)
- Bayer Healthcare Co., Ltd. (Beijing)
- Bayer Jinling Polyurethane Co., Ltd. (Nanjing)
- Bayer Polymers Shanghai Co., Ltd. (Shanghai)
- Bayer Polyurethanes Shanghai Co., Ltd. (Shanghai)
- Bayer Technology Services (Shanghai) Co., Ltd. (Shanghai)
- Bayer CropScience Hangzhou Co., Ltd. (Hangzhou)
- Bayer CropScience Tianjin Co., Ltd. (Tianjin)
- Hennecke Maruka (Shanghai) Limited
- Bayer MaterialScience Trading (Shanghai) Company Limited
 
Hong Kong
 
- Bayer MaterialScience Limited
- Bayer HealthCare Limited
 
 

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.